001367 海森药业
已收盘 07-17 15:00:00
资讯
新帖
简况
海森药业：截至2026年7月10日股东总户数约为0.9万户
证券之星 · 07-14
海森药业：截至2026年7月10日股东总户数约为0.9万户
7月12日海森药业发布公告，股东减持12.01万股
证券之星 · 07-12
7月12日海森药业发布公告，股东减持12.01万股
异动快报：海森药业（001367）7月3日9点34分触及涨停板
证券之星 · 07-03
异动快报：海森药业（001367）7月3日9点34分触及涨停板
海森药业（001367）披露注销部分募集资金现金管理产品专用结算账户公告，6月25日股价下跌2.01%
证券之星 · 06-25
海森药业（001367）披露注销部分募集资金现金管理产品专用结算账户公告，6月25日股价下跌2.01%
海森药业（001367）披露完成法定代表人工商变更登记公告，6月2日股价下跌2.7%
证券之星 · 06-02
海森药业（001367）披露完成法定代表人工商变更登记公告，6月2日股价下跌2.7%
海森药业（001367）披露变更持续督导保荐代表人公告，5月28日股价下跌1.28%
证券之星 · 05-28
海森药业（001367）披露变更持续督导保荐代表人公告，5月28日股价下跌1.28%
海森药业：截至2026年5月8日，公司股东总户数约为1.1万户
证券之星 · 05-13
海森药业：截至2026年5月8日，公司股东总户数约为1.1万户
海森药业（001367）披露2025年年度权益分派实施公告，5月6日股价下跌0.17%
证券之星 · 05-06
海森药业（001367）披露2025年年度权益分派实施公告，5月6日股价下跌0.17%
每周股票复盘：海森药业（001367）股东户数增36.27%至1.36万户
证券之星 · 05-03
每周股票复盘：海森药业（001367）股东户数增36.27%至1.36万户
股市必读：海森药业一季报 - 第一季度单季净利润同比下降7.38%
证券之星 · 04-29
股市必读：海森药业一季报 - 第一季度单季净利润同比下降7.38%
图解海森药业一季报：第一季度单季净利润同比下降7.38%
证券之星 · 04-28
图解海森药业一季报：第一季度单季净利润同比下降7.38%
海森药业：公司现有产品中没有胺类中间体
证券之星 · 04-21
海森药业：公司现有产品中没有胺类中间体
海森药业（001367）披露持股5%以上股东减持股份预披露公告，4月20日股价下跌4.08%
证券之星 · 04-20
海森药业（001367）披露持股5%以上股东减持股份预披露公告，4月20日股价下跌4.08%
4月19日增减持汇总：海森药业等3股拟减持，暂无A股增持（表）
新浪证券 · 04-19
4月19日增减持汇总：海森药业等3股拟减持，暂无A股增持（表）
海森药业最新公告：股东泰齐投资拟减持不超3.00%公司股份
证券之星 · 04-19
海森药业最新公告：股东泰齐投资拟减持不超3.00%公司股份
海森药业（001367）8066.74万股限售股将于4月14日解禁，占总股本52.95%
证券之星 · 04-14
海森药业（001367）8066.74万股限售股将于4月14日解禁，占总股本52.95%
海森药业（001367）披露2025年度网上业绩说明会安排，4月7日股价下跌0.81%
证券之星 · 04-07
海森药业（001367）披露2025年度网上业绩说明会安排，4月7日股价下跌0.81%
海森药业：截至2026年3月31日，公司股东总户数约为1.4万户
证券之星 · 04-02
海森药业：截至2026年3月31日，公司股东总户数约为1.4万户
股市必读：海森药业（001367）登3月27日交易所龙虎榜
证券之星 · 03-30
股市必读：海森药业（001367）登3月27日交易所龙虎榜
3月27日海森药业（001367）龙虎榜数据：机构净买入1412.45万元
证券之星 · 03-27
3月27日海森药业（001367）龙虎榜数据：机构净买入1412.45万元
暂无数据
公司概况
公司名称：
浙江海森药业股份有限公司
所属行业：
医药制造业
上市日期：
2023-04-10
主营业务：
浙江海森药业股份有限公司的主营业务是化学药品原料药及中间体研发、生产和销售。公司的主要产品是化学药品原料药、中间体。公司海外销售的比重较大，主要产品已通过国家GMP认证、部分产品通过美国FDA现场检查、墨西哥COFEPRIS现场检查、韩国MFDS认证；并获得欧洲CEP证书。
发行价格：
44.48
{"stockData":{"symbol":"001367","market":"SZ","secType":"STK","nameCN":"海森药业","latestPrice":18.7,"timestamp":1784271822000,"preClose":20.12,"halted":0,"volume":3055946,"delay":0,"changeRate":-0.0706,"floatShares":122000000,"shares":152000000,"eps":0.8768,"marketStatus":"已收盘","change":-1.42,"latestTime":"07-17 15:00:00","open":20.07,"high":20.07,"low":18.57,"amount":58482500,"amplitude":0.0746,"askPrice":18.7,"askSize":125,"bidPrice":18.68,"bidSize":62,"shortable":0,"etf":0,"ttmEps":0.8768,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784511000000},"marketStatusCode":5,"adr":0,"adjPreClose":20.12,"symbolType":"stock","openAndCloseTimeList":[[1784251800000,1784259000000],[1784264400000,1784271600000]],"highLimit":22.13,"lowLimit":18.11,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":152351200,"isCdr":false,"pbRate":2.01,"roa":"--","peRate":21.327555,"roe":"1.91%","epsLYR":0.91,"committee":0.169591,"marketValue":2849000000,"turnoverRate":0.0251,"status":1,"floatMarketCap":2275000000},"requestUrl":"/m/hq/s/001367/tweets","defaultTab":"tweets","newsList":[{"id":"2651285251","title":"海森药业：截至2026年7月10日股东总户数约为0.9万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2651285251","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651285251?lang=zh_cn&edition=full","pubTime":"2026-07-14 08:43","pubTimestamp":1783989786,"startTime":"0","endTime":"0","summary":"证券之星消息，海森药业(001367)07月13日在投资者关系平台上答复投资者关心的问题。投资者提问：请问6.30及7.10公司股东人数海森药业回复：尊敬的投资者，您好！根据中登公司最新下发的股东名册，截至2026年7月10日，公司股东总户数约为0.9万户。公司2026年6月30日的股东人数将于2026年半年度报告中披露，谢谢您的关注和支持本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400008436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650016819","title":"7月12日海森药业发布公告，股东减持12.01万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650016819","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650016819?lang=zh_cn&edition=full","pubTime":"2026-07-12 17:00","pubTimestamp":1783846855,"startTime":"0","endTime":"0","summary":"证券之星消息，7月12日海森药业发布公告《海森药业:关于持股5%以上股东提前终止减持计划暨减持结果的公告》，其股东东阳泰齐投资管理合伙企业(有限合伙)于2026年7月3日至2026年7月6日间合计减持12.01万股，占公司目前总股本的0.0788%，变动期间该股股价上涨2.9%，截止7月6日收盘报19.9元。股东增减持详情见下表：根据海森药业2026年一季报公布的十大股东详情如下：本文数据来源于海森药业公告，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200007835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648324886","title":"异动快报：海森药业（001367）7月3日9点34分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2648324886","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648324886?lang=zh_cn&edition=full","pubTime":"2026-07-03 09:35","pubTimestamp":1783042543,"startTime":"0","endTime":"0","summary":"证券之星7月3日盘中消息，9点34分海森药业（001367）触及涨停板。其所属行业化学制药目前上涨。领涨股为向日葵。该股为医药，化学原料药概念热股，当日医药概念上涨1.5%，化学原料药概念上涨1.35%。7月2日的资金流向数据方面，主力资金净流入91.25万元，占总成交额2.42%，游资资金净流入14.38万元，占总成交额0.38%，散户资金净流出105.63万元，占总成交额2.8%。近5日资金流向一览见下表：海森药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300010913.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646801165","title":"海森药业（001367）披露注销部分募集资金现金管理产品专用结算账户公告，6月25日股价下跌2.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646801165","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646801165?lang=zh_cn&edition=full","pubTime":"2026-06-25 23:03","pubTimestamp":1782399802,"startTime":"0","endTime":"0","summary":"截至2026年6月25日收盘，海森药业报收于19.06元，较前一交易日下跌2.01%，最新总市值为29.04亿元。近日，浙江海森药业股份有限公司发布《关于注销部分募集资金现金管理产品专用结算账户的公告》。公告显示，因浙商证券股份有限公司东阳环城北路证券营业部的募集资金现金管理产品专用结算账户已不再使用且无后续使用计划，公司决定注销该账户，账户资金账号为537023832。其余相关账户仍正常使用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500044750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640914968","title":"海森药业（001367）披露完成法定代表人工商变更登记公告，6月2日股价下跌2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640914968","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640914968?lang=zh_cn&edition=full","pubTime":"2026-06-02 18:15","pubTimestamp":1780395319,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，海森药业报收于20.17元，较前一交易日下跌2.7%，最新总市值为30.73亿元。近日，浙江海森药业股份有限公司发布公告称，公司于2026年4月27日召开第三届董事会第二十次会议，审议通过选举王雨潇为公司董事长及代表公司执行公司事务的董事，据此变更法定代表人。公司已完成相关工商变更登记手续，并取得浙江省市场监督管理局换发的营业执照，法定代表人由王式跃变更为王雨潇，其他营业执照内容不变。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200036496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638669449","title":"海森药业（001367）披露变更持续督导保荐代表人公告，5月28日股价下跌1.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638669449","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638669449?lang=zh_cn&edition=full","pubTime":"2026-05-28 22:58","pubTimestamp":1779980292,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘，海森药业报收于20.85元，较前一交易日下跌1.28%，最新总市值为31.77亿元。近日，浙江海森药业股份有限公司发布公告，由于原持续督导保荐代表人徐峰先生因工作变动不再担任相关职务，中信证券委派郭阳先生接替其工作。变更后，持续督导保荐代表人为董超先生和郭阳先生，督导期至中国证监会和深交所规定的义务结束为止。本次变更不影响持续督导工作和公司正常经营。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800043664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635427580","title":"海森药业：截至2026年5月8日，公司股东总户数约为1.1万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2635427580","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635427580?lang=zh_cn&edition=full","pubTime":"2026-05-13 11:34","pubTimestamp":1778643264,"startTime":"0","endTime":"0","summary":"证券之星消息，海森药业(001367)05月12日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，请问一下贵公司5月10日股东人数是多少？海森药业回复：尊敬的投资者，您好！根据中登公司最新下发的股东名册，截至2026年5月8日，公司股东总户数约为1.1万户。谢谢您的关注和支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300017756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633186792","title":"海森药业（001367）披露2025年年度权益分派实施公告，5月6日股价下跌0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633186792","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633186792?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:09","pubTimestamp":1778062175,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，海森药业报收于23.66元，较前一交易日下跌0.17%，最新总市值为36.05亿元。该股当日开盘23.7元，最高23.79元，最低23.14元，成交额达1.05亿元，换手率为3.67%。公司于近日披露《2025年年度权益分派实施公告》。公告显示，浙江海森药业股份有限公司2025年年度权益分派方案已获股东会审议通过，以公司总股本152,351,200股为基数，向全体股东每10股派1.16元现金（含税）。本次分配方案与股东会审议通过的一致，且实施时间未超过两个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600029249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632667720","title":"每周股票复盘：海森药业（001367）股东户数增36.27%至1.36万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2632667720","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632667720?lang=zh_cn&edition=full","pubTime":"2026-05-03 06:08","pubTimestamp":1777759697,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，海森药业报收于23.7元，较上周的25.46元下跌6.91%。本周，海森药业4月27日盘中最高价报25.99元。海森药业当前最新总市值36.11亿元，在化学制药板块市值排名123/150，在两市A股市值排名4242/5200。本周关注点股本股东变化：股东户数增36.27%至1.36万户业绩披露要点：一季度主营收入1.07亿元，同比下降9.53%股本股东变化股东户数变动截至2026年3月31日，公司股东户数为1.36万户，较3月20日增加3627.0户，增幅36.27%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631530939","title":"股市必读：海森药业一季报 - 第一季度单季净利润同比下降7.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631530939","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631530939?lang=zh_cn&edition=full","pubTime":"2026-04-29 07:26","pubTimestamp":1777418781,"startTime":"0","endTime":"0","summary":"来自业绩披露要点：2026年一季度海森药业主营收入同比下降9.53%，归母净利润同比下降7.38%。股本股东变化股东户数变动近日海森药业披露，截至2026年3月31日公司股东户数为1.36万户，较3月20日增加3627.0户，增幅为36.27%。业绩披露要点财务报告海森药业2026年一季报显示，一季度公司主营收入1.07亿元，同比下降9.53%；归母净利润2890.84万元，同比下降7.38%；扣非净利润2750.82万元，同比下降8.77%；负债率6.54%，投资收益127.35万元，财务费用52.53万元，毛利率48.19%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900021700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630106293","title":"图解海森药业一季报：第一季度单季净利润同比下降7.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630106293","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630106293?lang=zh_cn&edition=full","pubTime":"2026-04-28 04:35","pubTimestamp":1777322113,"startTime":"0","endTime":"0","summary":"证券之星消息，海森药业2026年一季报显示，一季度公司主营收入1.07亿元，同比下降9.53%；归母净利润2890.84万元，同比下降7.38%；扣非净利润2750.82万元，同比下降8.77%；负债率6.54%，投资收益127.35万元，财务费用52.53万元，毛利率48.19%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800012422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629709937","title":"海森药业：公司现有产品中没有胺类中间体","url":"https://stock-news.laohu8.com/highlight/detail?id=2629709937","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629709937?lang=zh_cn&edition=full","pubTime":"2026-04-21 11:34","pubTimestamp":1776742465,"startTime":"0","endTime":"0","summary":"证券之星消息，海森药业(001367)04月21日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘您好，三月份巴斯夫宣布胺类中间体涨价，贵公司自研的胺类中间体工艺成熟，纯度也高，也通过了欧美认证，完全有能力巴斯夫涨价后的转单需求，请问贵司这段时间来是否因此受益？比如订单增多或者利润变大？海森药业回复：尊敬的投资者，您好！公司现有产品中没有胺类中间体。公司主要产品为硫糖铝、安乃近、阿托伐他汀钙、PHBA等原料药及中间体产品。感谢您的关注和支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100024659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628463707","title":"海森药业（001367）披露持股5%以上股东减持股份预披露公告，4月20日股价下跌4.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628463707","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628463707?lang=zh_cn&edition=full","pubTime":"2026-04-20 17:22","pubTimestamp":1776676937,"startTime":"0","endTime":"0","summary":"截至2026年4月20日收盘，海森药业报收于25.41元，较前一交易日下跌4.08%，最新总市值为38.71亿元。公司于近日披露《关于持股5%以上股东减持股份的预披露公告》。公告显示，浙江海森药业股份有限公司持股5%以上股东东阳泰齐投资管理合伙企业计划自2026年5月14日至8月13日，通过集中竞价交易和大宗交易方式减持公司股份不超过4,570,536股，占公司总股本比例3.00%。本次减持原因为员工自身资金需求，股份来源为首次公开发行前持有的股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000023976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628694477","title":"4月19日增减持汇总：海森药业等3股拟减持，暂无A股增持（表）","url":"https://stock-news.laohu8.com/highlight/detail?id=2628694477","media":"新浪证券","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628694477?lang=zh_cn&edition=full","pubTime":"2026-04-19 17:27","pubTimestamp":1776590820,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 据统计，4月19日，海森药业、华塑控股、正泰电源（维权）3家A股上市公司披露拟减持情况，暂无公司披露增持情况。\n\n\n新浪声明：此消息系转载自新浪合作媒体，新浪网登载此文出于传递更多信息之目的，并不意味着赞同其观点或证实其描述。文章内容仅供参考，不构成投资建议。投资者据此操作，风险自担。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：宋雅芳","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-04-19/doc-inhuzsuz9209085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159982","BK0239","001367","399300"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628693097","title":"海森药业最新公告：股东泰齐投资拟减持不超3.00%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2628693097","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628693097?lang=zh_cn&edition=full","pubTime":"2026-04-19 16:50","pubTimestamp":1776588614,"startTime":"0","endTime":"0","summary":"海森药业(001367.SZ)公告称，持股5%以上股东东阳泰齐投资管理合伙企业(有限合伙)计划自本公告披露之日起15个交易日后的3个月内，以集中竞价交易、大宗交易方式减持公司股份不超过457.05万股，占公司总股本比例3.00%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900007205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627462355","title":"海森药业（001367）8066.74万股限售股将于4月14日解禁，占总股本52.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627462355","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627462355?lang=zh_cn&edition=full","pubTime":"2026-04-14 08:10","pubTimestamp":1776125442,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，海森药业于4月14日将有8066.74万股限售股份解禁，为公司首发原股东限售股份，占公司总股本52.95%。最近一年内，该股累计解禁98.88万股，占总股本的0.65%。本次解禁后，公司还有3071.42万股限售股份，占总股本20.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400005624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625939370","title":"海森药业（001367）披露2025年度网上业绩说明会安排，4月7日股价下跌0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625939370","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625939370?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:36","pubTimestamp":1775554577,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘，海森药业报收于25.82元，较前一交易日下跌0.81%，最新总市值为39.34亿元。该股当日开盘26.27元，最高26.98元，最低25.71元，成交额达1.85亿元，换手率为17.89%。近日，海森药业发布《关于举行2025年度网上业绩说明会的公告》。公司自即日起至2026年4月9日12:00前公开征集投资者问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700024511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624249775","title":"海森药业：截至2026年3月31日，公司股东总户数约为1.4万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2624249775","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624249775?lang=zh_cn&edition=full","pubTime":"2026-04-02 11:36","pubTimestamp":1775100972,"startTime":"0","endTime":"0","summary":"证券之星消息，海森药业(001367)04月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2026年3月 31日公司的股东总数是多少？谢谢海森药业回复：尊敬的投资者，您好！根据中登公司最新下发的股东名册，截至2026年3月31日，公司股东总户数约为1.4万户。谢谢您的关注和支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200015200.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623352022","title":"股市必读：海森药业（001367）登3月27日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2623352022","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623352022?lang=zh_cn&edition=full","pubTime":"2026-03-30 01:45","pubTimestamp":1774806315,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，海森药业报收于25.18元，上涨4.39%，换手率44.5%，成交量17.71万手，成交额4.49亿元。当日关注点来自交易信息汇总：3月27日主力资金净流入2830.03万元，游资资金同步净流入1771.18万元。来自龙虎榜上榜：海森药业因日换手率达20%进入沪深交易所龙虎榜，为近5个交易日内首次上榜。龙虎榜上榜沪深交易所2026年3月27日公布的交易公开信息显示，海森药业因日换手率达到20%的前5只证券登上龙虎榜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000000381.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622444398","title":"3月27日海森药业（001367）龙虎榜数据：机构净买入1412.45万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622444398","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622444398?lang=zh_cn&edition=full","pubTime":"2026-03-27 17:16","pubTimestamp":1774603009,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年3月27日公布的交易公开信息显示，海森药业因日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年3月27日收盘，海森药业报收于25.18元，上涨4.39%，换手率44.5%，成交量17.71万手，成交额4.49亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入1412.45万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700035958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1784277484506,"stockEarnings":[{"period":"1week","weight":0.0876},{"period":"1month","weight":-0.0327},{"period":"3month","weight":-0.2369},{"period":"6month","weight":-0.1626},{"period":"1year","weight":-0.1567},{"period":"ytd","weight":-0.079}],"compareEarnings":[{"period":"1week","weight":-0.0382},{"period":"1month","weight":-0.0512},{"period":"3month","weight":-0.0417},{"period":"6month","weight":-0.0535},{"period":"1year","weight":0.1081},{"period":"ytd","weight":-0.0218}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江海森药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"9000人(较上一季度减少18.18%)","perCapita":"13515股","listingDate":"2023-04-10","address":"浙江省金华市东阳市六石街道香潭村","registeredCapital":"15235万元","survey":" 浙江海森药业股份有限公司的主营业务是化学药品原料药及中间体研发、生产和销售。公司的主要产品是化学药品原料药、中间体。公司海外销售的比重较大，主要产品已通过国家GMP认证、部分产品通过美国FDA现场检查、墨西哥COFEPRIS现场检查、韩国MFDS认证；并获得欧洲CEP证书。","listedPrice":44.48},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海森药业(001367)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海森药业(001367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海森药业,001367,海森药业股票,海森药业股票老虎,海森药业股票老虎国际,海森药业行情,海森药业股票行情,海森药业股价,海森药业股市,海森药业股票价格,海森药业股票交易,海森药业股票购买,海森药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海森药业(001367)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海森药业(001367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}